MongoDB stock price target raised to $465 from $415 at DA Davidson

Published 02-12-2025, 08:56 pm
MongoDB stock price target raised to $465 from $415 at DA Davidson

Investing.com - DA Davidson has raised its price target on MongoDB (NASDAQ:MDB) to $465 from $415 while maintaining a Buy rating on the stock. The new target represents potential upside from the current price of $412.77, with MongoDB currently trading near its 52-week high. According to InvestingPro data, the stock has seen an impressive 70.4% price return over the past six months.

The price target increase follows MongoDB’s quarterly results, which DA Davidson described as "another strong beat & raise" with Atlas accelerating for the second straight quarter to 30% year-over-year growth compared to 29% in the previous quarter.

The firm noted that strong performance in both Non-Atlas and Enterprise Advanced segments, combined with continued cost discipline, helped drive a substantial operating profit beat. While MongoDB is not yet profitable over the last twelve months, InvestingPro analysis indicates analysts predict the company will be profitable this fiscal year with an EPS forecast of $3.98.

MongoDB’s fiscal year 2026 guidance was raised "significantly all around," according to DA Davidson, while the fourth-quarter Atlas growth guidance of 27% year-over-year suggests that 30%+ year-over-year Atlas growth is achievable by the end of the year, considering typical guidance conservatism.

DA Davidson maintained its Buy rating on MongoDB stock while implementing the price target increase from $415 to $465.

In other recent news, MongoDB reported third-quarter results that exceeded analyst expectations, with revenue surpassing projections by $37 million. This strong performance led the company to raise its full-year guidance. MongoDB’s Atlas platform showed notable growth, accelerating to 30% year-over-year, which was above the company’s earlier guidance. As a result, several firms have adjusted their price targets for MongoDB. Piper Sandler increased its price target from $400 to $490, citing the accelerating growth in the Atlas platform. Oppenheimer raised its target to $450, highlighting the strong quarterly results and broad-based demand. Bernstein SocGen Group also increased its price target to $452, noting that both the Q3 performance and fourth-quarter guidance exceeded consensus estimates. Lastly, Scotiabank adjusted its price target to $415, emphasizing the impressive third-quarter earnings and improved profitability. KeyBanc Capital Markets maintained its Sector Weight rating, acknowledging the company’s robust financial results.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.